Novartis Investigative Site

Dalian 116000

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease, Primary Immune Thrombocytopenia (ITP), Triple Negative Breast Neoplasms, Type 2 Diabetes Mellitus, Warm Autoimmune Hemolytic Anemia (wAIHA)

Studies at this site

• A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia — Running, not enrolling
• Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss — Stopped early
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early